204 related articles for article (PubMed ID: 26335662)
1. Concurrent acute Vogt-Koyanagi-Harada disease in one eye and chronic disease in the fellow eye.
Khochtali S; Abroug N; Hani MS; Khairallah-Ksiaa I; Jelliti B; Khairallah M
J Ophthalmic Inflamm Infect; 2015 Dec; 5(1):57. PubMed ID: 26335662
[TBL] [Abstract][Full Text] [Related]
2. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
4. Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.
AlBloushi AF; Herbort CP; Abu El-Asrar AM
Int Ophthalmol; 2021 Dec; 41(12):4187-4195. PubMed ID: 34346004
[TBL] [Abstract][Full Text] [Related]
5. Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome.
Hosseini SM; Dourandish M; Mazouchi M
J Ophthalmic Vis Res; 2020; 15(1):99-103. PubMed ID: 32128086
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
7. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
9. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
Obata S; Saishin Y; Teramura K; Ohji M
Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
Shin WB; Kim MK; Lee CS; Lee SC; Kim H
Korean J Ophthalmol; 2015 Dec; 29(6):389-95. PubMed ID: 26635455
[TBL] [Abstract][Full Text] [Related]
11. VKH with APECED in a Two-Year-Old Child: A Rare Concomitant Diagnosis in an Unprecedented Age.
Hassan LM; Hassan MM; Abou Shady H; Khedr D
Ocul Immunol Inflamm; 2024 May; 32(4):433-436. PubMed ID: 38412247
[TBL] [Abstract][Full Text] [Related]
12. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
Keino H; Goto H; Usui M
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Koyanagi-Harada disease is always bilateral: reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye.
Papasavvas I; Herbort CP
J Ophthalmic Inflamm Infect; 2021 Feb; 11(1):6. PubMed ID: 33559795
[TBL] [Abstract][Full Text] [Related]
14. Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease.
Huang Y; Yang YT; Lin B; Huang SH; Sun ZH; Zhou R; Li YZ; Liu XL
Int J Ophthalmol; 2020; 13(12):1928-1932. PubMed ID: 33344192
[TBL] [Abstract][Full Text] [Related]
15. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
Lee EK; Lee SY; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
[TBL] [Abstract][Full Text] [Related]
16. Early manifestation of vogt-koyanagi-harada disease as unilateral posterior scleritis.
Kouda N; Sasaki H; Harada S; Yamada Y; Takahashi N; Sasaki K
Jpn J Ophthalmol; 2002; 46(5):590-3. PubMed ID: 12457922
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature.
Rahman N; Artiaga JCM; Bouras K; Luis J; Rees A; Westcott M
J Ophthalmic Inflamm Infect; 2023 May; 13(1):27. PubMed ID: 37204477
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
19. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
